{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:34:07Z","timestamp":1790282047296,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.hbpd.2021.04.010","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T02:57:51Z","timestamp":1619578671000},"page":"315-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Mitochondria: A critical hub for hepatic stellate cells activation during chronic liver diseases"],"prefix":"10.1016","volume":"20","author":[{"given":"Devaraj","family":"Ezhilarasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2021.04.010_bib0001","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/14728214.2020.1735350","article-title":"Novel targeted therapies for the management of liver fibrosis","volume":"25","author":"Trivella","year":"2020","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0002","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ajg.2018.03.002","article-title":"Oxidative stress is bane in chronic liver diseases: clinical and experimental perspective","volume":"19","author":"Ezhilarasan","year":"2018","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0003","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1535370219898141","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar","year":"2020","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0004","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0005","series-title":"Nanoparticles and their biomedical applications","article-title":"Nanomedicine for hepatic fibrosis","author":"Devaraj","year":"2020"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0006","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2020.03.011","article-title":"Hepatic fibrosis: a convergent response to liver injury that is reversible","volume":"73","author":"Wang","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0007","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.hbpd.2018.04.003","article-title":"Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets","volume":"17","author":"Ezhilarasan","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0008","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00535-017-1404-4","article-title":"Human hepatic stellate cell isolation and characterization","volume":"53","author":"Shang","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0009","series-title":"Phytochemicals as lead compounds for new drug discovery: Recent advances","article-title":"Lead compounds with the potentials for the treatment of chronic liver diseases","author":"Ezhilarasan","year":"2019"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0010","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4254\/wjh.v11.i5.412","article-title":"Roles of hepatic stellate cells in acute liver failure: from the perspective of inflammation and fibrosis","volume":"11","author":"Li","year":"2019","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0011","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev-cellbio-100617-062855","article-title":"Stellate cells in tissue repair, inflammation, and cancer","volume":"34","author":"Sherman","year":"2018","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0012","article-title":"Retinoids in health and disease: a role for hepatic stellate cells in affecting retinoid levels","volume":"1865","author":"Haaker","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0013","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jhep.2017.06.001","article-title":"Hepatic stellate cell activation and pro-fibrogenic signals","volume":"67","author":"Gandhi","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0014","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/387626","article-title":"Mitochondrial roles and cytoprotection in chronic liver injury","volume":"2012","author":"Degli Esposti","year":"2012","journal-title":"Biochem Res Int"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0017","first-page":"6","article-title":"Reduced mitochondrial dysfunction delays liver fibrosis","volume":"7","author":"Higgs","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0018","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial dysfunction and signaling in chronic liver diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0019","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biocel.2017.12.019","article-title":"Mitochondria in non-alcoholic fatty liver disease","volume":"95","author":"Sim\u00f5es","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0020","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bbrc.2016.11.088","article-title":"The role of mitochondria in metabolism and cell death","volume":"482","author":"Vakifahmetoglu-Norberg","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0021","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.bbadis.2018.09.011","article-title":"Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell","volume":"1864","author":"Ai","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0022","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jnutbio.2019.06.001","article-title":"Astaxanthin attenuates the increase in mitochondrial respiration during the activation of hepatic stellate cells","volume":"71","author":"Bae","year":"2019","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0023","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/jcmm.13501","article-title":"Elevated mitochondrial activity distinguishes fibrogenic hepatic stellate cells and sensitizes for selective inhibition by mitotropic doxorubicin","volume":"22","author":"Gajendiran","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0024","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3390\/cells8101119","article-title":"Serine protease HtrA2\/Omi deficiency impairs mitochondrial homeostasis and promotes hepatic fibrogenesis via activation of hepatic stellate cells","volume":"8","author":"Hur","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0025","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","article-title":"Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation","volume":"73","author":"Bates","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0026","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","article-title":"Hedgehog-YAP signaling pathway regulates glutaminolysis to control activation of hepatic stellate cells","volume":"154","author":"Du","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0027","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/cells8080795","article-title":"Mitochondrial uncoupling: a key controller of biological processes in physiology and diseases","volume":"8","author":"Demine","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0028","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbrc.2008.11.141","article-title":"TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis","volume":"379","author":"Fujisawa","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0029","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-230X-12-68","article-title":"Mitochondrial uncouplers inhibit hepatic stellate cell activation","volume":"12","author":"Guimar\u00e3es","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0030","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1073\/pnas.0702683104","article-title":"A fundamental system of cellular energy homeostasis regulated by PGC-1alpha","volume":"104","author":"Rohas","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0031","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1053\/j.gastro.2012.07.115","article-title":"Hedgehog controls hepatic stellate cell fate by regulating metabolism","volume":"143","author":"Chen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0032","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/iub.1518","article-title":"Curcumin inhibits aerobic glycolysis in hepatic stellate cells associated with activation of adenosine monophosphate-activated protein kinase","volume":"68","author":"Lian","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0033","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fcell.2018.00150","article-title":"Role of metabolism in hepatic stellate cell activation and fibrogenesis","volume":"6","author":"Hou","year":"2018","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0034","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1038\/s41598-017-03782-x","article-title":"Thymosin beta-4 regulates activation of hepatic stellate cells via hedgehog signaling","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0035","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.7150\/ijbs.28089","article-title":"Role of canonical Hedgehog signaling pathway in liver","volume":"14","author":"Gao","year":"2018","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0036","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/path.3005","article-title":"The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells","volume":"226","author":"Novo","year":"2012","journal-title":"J Pathol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0037","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/cells7090137","article-title":"Retinoids issued from hepatic stellate cell lipid droplet loss as potential signaling molecules orchestrating a multicellular liver injury response","volume":"7","author":"Bobowski-Gerard","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0038","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.aninu.2015.08.008","article-title":"Glutamine and glutamate: nonessential or essential amino acids?","volume":"1","author":"Watford","year":"2015","journal-title":"Anim Nutr"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0039","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.cmet.2019.01.016","article-title":"Glutamine metabolism regulates proliferation and lineage allocation in skeletal stem cells","volume":"29","author":"Yu","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0040","article-title":"Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0041","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fcell.2019.00033","article-title":"Hippo signaling in the liver - a long and ever-expanding story","volume":"7","author":"Manmadhan","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0042","doi-asserted-by":"crossref","first-page":"9602","DOI":"10.1096\/fj.201900213R","article-title":"ATP-citrate lyase is an epigenetic regulator to promote obesity-related kidney injury","volume":"33","author":"Chen","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0043","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4155\/fmc-2019-0312","article-title":"Recent development in acetyl-CoA carboxylase inhibitors and their potential as novel drugs","volume":"12","author":"Wu","year":"2020","journal-title":"Future Med Chem"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0044","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.toxlet.2016.09.014","article-title":"Upregulation of SIRT1-AMPK by thymoquinone in hepatic stellate cells ameliorates liver injury","volume":"262","author":"Yang","year":"2016","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0045","doi-asserted-by":"crossref","first-page":"62780","DOI":"10.18632\/oncotarget.19376","article-title":"AMPK: a novel target for treating hepatic fibrosis","volume":"8","author":"Liang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0046","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/hep.21995","article-title":"Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells","volume":"47","author":"Caligiuri","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0047","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0048","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/labinvest.2009.77","article-title":"Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787\/ZK22258","volume":"89","author":"Liu","year":"2009","journal-title":"Lab Invest"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0049","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/10715760903555836","article-title":"Thiol redox systems and protein kinases in hepatic stellate cell regulatory processes","volume":"44","author":"Brunati","year":"2010","journal-title":"Free Radic Res"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0050","first-page":"1","article-title":"Oxidative stress and hepatic stellate cells: a PARADOXICAL relationship","volume":"7","author":"Gandhi","year":"2012","journal-title":"Trends Cell Mol Biol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0051","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.freeradbiomed.2005.04.015","article-title":"Role of reactive oxygen species in zinc deficiency-induced hepatic stellate cell activation","volume":"39","author":"Kojima-Yuasa","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0052","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1096\/fj.06-7717com","article-title":"The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species","volume":"21","author":"Siegmund","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0053","first-page":"40","article-title":"Silibinin alleviates N-nitrosodimethylamine-induced glutathione dysregulation and hepatotoxicity in rats","volume":"14","author":"Ezhilarasan","year":"2016","journal-title":"Chin J Nat Med"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0054","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.taap.2010.11.016","article-title":"Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice","volume":"251","author":"Ghatak","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0055","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.etap.2012.07.004","article-title":"Ameliorative effect of silibinin against N-nitrosodimethylamine-induced hepatic fibrosis in rats","volume":"34","author":"Ezhilarasan","year":"2012","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0056","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12404","article-title":"Melatonin protects against lipid-induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice","volume":"62","author":"Das","year":"2017","journal-title":"J Pineal Res"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0057","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.7150\/thno.29620","article-title":"p66Shc contributes to liver fibrosis through the regulation of mitochondrial reactive oxygen species","volume":"9","author":"Zhao","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0058","doi-asserted-by":"crossref","first-page":"G374","DOI":"10.1152\/ajpgi.00032.2018","article-title":"Role of mitophagy regulation by ROS in hepatic stellate cells during acute liver failure","volume":"315","author":"Tian","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0059","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3748\/wjg.v24.i7.819","article-title":"Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells in vivo and in vitro by activating AMP-activated protein kinase","volume":"24","author":"Li","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.04.010_bib0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s11658-019-0179-4","article-title":"Costunolide reduces glycolysis-associated activation of hepatic stellate cells via inhibition of hexokinase-2","volume":"24","author":"Ban","year":"2019","journal-title":"Cell Mol Biol Lett"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387221000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387221000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:41:36Z","timestamp":1761493296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387221000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1499387221000795"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2021.04.010","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondria: A critical hub for hepatic stellate cells activation during chronic liver diseases","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2021.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}